Navigation Links
Chipscreen and HUYA Bioscience to Present Clinical Data on Novel HDAC Inhibitor at the 2009 ASCO Annual Meeting
Date:5/28/2009

SHENZHEN, China and SAN DIEGO, May 28 /PRNewswire/ -- Shenzhen Chipscreen Biosciences, Ltd., and HUYA Bioscience International, LLC, today announced that final data from a Phase 1 trial conducted by Chipscreen of the investigational compound chidamide (CS055/HBI-8000) will be presented at the 2009 American Society of Clinical Oncology (ASCO) Annual Meeting, which will be held from May 29 to June 2, 2009, in Orlando, Florida. Chidamide/HBI-8000 is a novel benzamide class histone deacetylase (HDAC) inhibitor in development by Chipscreen and HUYA for oncology indications. The data to be presented will include safety, pharmacokinetics, and biomarker and anti-tumor activity (abstract #3529).

                  Title:  "Phase 1 study of chidamide (CS055/HBI-8000), a
                          novel histone deacetylase inhibitor, in patients
                          with advanced solid tumors and lymphomas"

    Poster Presentation:  Friday, May 29, 2 pm - 6 pm EDT, Level 3, W315A,
                          Board 13

      Poster Discussion:  Friday, May 29, 5 pm - 6 pm EDT, Level 4, Valencia
                          Room, W415D

Shenzhen Chipscreen Biosciences is a leading China-based biotechnology company that specializes in discovering and developing proprietary small molecule therapeutics for unmet medical needs. The company is utilizing its proprietary chemical genomics-based discovery platform to develop a portfolio of clinical and preclinical stage programs in a number of therapeutic areas. The core competence of the company is the science-driven approach in discovery, strong pipeline building capability, experience with IP, and regulatory expertise. Additional information about the company is available at www.chipscreen.com.

HUYA Bioscience International is a leader in enabling and accelerating the global co-development of no
'/>"/>

SOURCE HUYA Bioscience International, LLC
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Chipscreen Biosciences and HUYA Bioscience Intl Announce Promising Preclincial and Phase I Solid Tumor/Lymphoma Data for Chidamide/HBI-8000, New HDAC Inhibitor for Cancer
2. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
3. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
4. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
5. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
6. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
7. Ardea Biosciences Lead MEK Inhibitor, RDEA119, to Enter Human Clinical Trials in Advanced Cancer Patients
8. Alacrity Biosciences Announces Positive Results from a Phase 2 Study of Its Dry Eye Treatment ALTY-0501
9. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
10. Regado Biosciences Initiates Phase IIa Clinical Study of REG1 Anticoagulation System
11. Regado Biosciences Presents Positive Data From REG1 Anticoagulation System Phase Ic Study at American Heart Association 2007 Scientific Sessions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... /PRNewswire-iReach/ -- ScriptPro has been certified by the ... Security Framework (CSF). According to Russ Hailey ... appreciate this rigorous, top-to-bottom audit. Security-minded customers depend ... signifies. Our business partners need to know we ... PROCESS: ScriptPro,s internal security processes and controls were ...
(Date:8/21/2014)... Aug. 21, 2014  ACI Clinical ( www.aciclinical.com ... Data Monitoring Committees. Using this solution, ... over industry standard costs and receive the same ... in committee services. Leveraging a decade ... contracting, charter development, statistical programming and meeting facilitation), ...
(Date:8/21/2014)... SAN FRANCISCO , Aug. 21, 2014 ... U.S. Food and Drug Administration (FDA) has ... to detect atrial fibrillation (AFib), the most ... analysis process (algorithm) instantly detects if patients ... recordings taken on the mobile phone based ...
Breaking Medicine Technology:ScriptPro Achieves HITRUST Certification 2ACI Clinical: Innovation and Savings in Data Safety Monitoring Committees 2AliveCor Receives First FDA Clearance to Detect a Serious Heart Condition in an ECG on a Mobile Device 2
... Industry-Funded Immune Globulin Study Uncovers Sample,Manipulation, Design ... -- An analysis,released today critically examined a ... autism and Rh immune globulin,(RhIg) injections, some ... extensive design flaws, the,analysis uncovered manipulation of ...
... OSS, the Netherlands, June 27, 2007-Organon, the human,healthcare ... two,out of three Phase III clinical trials with ... have reached,their randomization target. , ,Corifollitropin alfa ... first of a new class of gonadotropins (a ...
Cached Medicine Technology:Genetics Journal Thimerosal/Autism Study the 'Best Science Drug,Company Money Can Buy' 2Genetics Journal Thimerosal/Autism Study the 'Best Science Drug,Company Money Can Buy' 3Two Phase III clinical trials on corifollitropin alfa (Org 36286),reach randomization target 2Two Phase III clinical trials on corifollitropin alfa (Org 36286),reach randomization target 3
(Date:8/21/2014)... THURSDAY, Aug. 21, 2014 (HealthDay News) -- Black mothers ... babies, and here,s one possible reason why: Hospitals in ... nursing than those in areas with more white residents, ... support breast-feeding are much less common in medical centers ... from the U.S. Centers for Disease Control and Prevention ...
(Date:8/21/2014)... born at a low birth weight puts black women at ... The findings may partly explain high diabetes rates among ... low birth weight, the researchers added. Their study of ... low birth weight were 13 percent more likely to develop ... The risk of diabetes was 40 percent higher in those ...
(Date:8/21/2014)... Dennis Thompson HealthDay Reporter ... A combination of therapy and antidepressants appears to best ... study reports. Four out of five people suffering ... full recovery when treated with cognitive therapy plus antidepressant ... combination didn,t work much better than drugs alone in ...
(Date:8/21/2014)... August 21, 2014 Transvaginal mesh ... Inc. continue to move forward in the federal ... District of West Virginia, Bernstein Liebhard LLP reports. ... 14th, the Court has established new stipulated evidence ... handling, division, storage and preservation. (In re C.R. ...
(Date:8/21/2014)... 21, 2014 Seattle, WA chiropractors ... Eastlake Chiropractic and Massage Center have recently ... team. Rina Lang, LMP and Mike Larios, LMP ... of massage techniques, and have developed their expertise working ... is particularly important in a clinical environment where massage ...
Breaking Medicine News(10 mins):Health News:Racial Disparities in Breast-Feeding May Start With Hospitals, Study Suggests 2Health News:Low Birth Weights May Put Black Women at Risk for Diabetes 2Health News:Talk Therapy Plus Meds May Be Best for Severe Depression 2Health News:Talk Therapy Plus Meds May Be Best for Severe Depression 3Health News:Transvaginal Mesh Lawsuits Move Forward in Federal C.R. Bard Litigation with Issuance of New Pretrial Order, Bernstein Liebhard LLP Reports 2Health News:Transvaginal Mesh Lawsuits Move Forward in Federal C.R. Bard Litigation with Issuance of New Pretrial Order, Bernstein Liebhard LLP Reports 3Health News:Seattle’s Eastlake Chiropractic and Massage Center Is Pleased to Introduce Rina Lang and Mike Larios as New Members of Its Massage Therapy Team 2Health News:Seattle’s Eastlake Chiropractic and Massage Center Is Pleased to Introduce Rina Lang and Mike Larios as New Members of Its Massage Therapy Team 3
... are used in some men to help them improve ... characteristics. Apparently the same patches can be used in ... their sexual desire and activity. ,In a study ... have looked at 447 women diagnosed with hypoactive sexual ...
... want to know answers to everything. This gains special// importance ... often have we questioned the diseases that make our precious ... ,Researchers in a breakthrough have unraveled the mystery surrounding heart ... failure, the heart uses too much fatty acid and not ...
... disease is responsible for nearly half (49 per cent) ... million people each year. Reducing cholesterol is one of ... ,Both soy protein and plant sterols extracted from ... foods market, with the US Food and Drug Administration ...
... D in bone development and teeth// strengthening is well known. Children ... the body with this vital nutrient. Vitamin D is produced in ... exposed to sunlight too. So much so that parents want their ... vitamin, which is free in nature! All this is done to ...
... tomographic colonography (CTC) depicts cancers and other clinically important conditions ... at very little additional cost, according to a study in ... finding cancer outside the colon may be as significant as ... Yee, M.D., Chief of Radiology at the Veterans Affairs Medical ...
... causes that can cause hearing loss in people apart// ... and type 1 diabetes. The researches are featured in ... ,In the first study researchers have found a previously ... form of hearing loss due to a lesion of ...
Cached Medicine News:Health News:Testosterone Patches Found To Increase Sexual Desire In Menopausal Women 2Health News:Calcium-Vitamin D Combo For Reduced Fracture Risk 2Health News:Calcium-Vitamin D Combo For Reduced Fracture Risk 3Health News:Virtual Colonoscopy May Be Better Than Real-time Colonoscopy 2Health News:Studies On Hearing Loss Discovers New Causes 2
The P45 Ultrasonic Workstation provides the highest ultrasound resolution for imaging....
EchoScan US-2500 is available in a single configuration or in combination with the A scan for maximum cost efficiency....
PremierEdge Stab Knives - 30....
... in the 21st century requires ... Alcon® UltraScan® imaging system responds ... at clinical echographic needs in ... permits step-by-step processing to collect ...
Medicine Products: